Alzheimer Disease and Dementia
Medicare Coverage of Aducanumab for Alzheimer Disease: The Impact of the Decision
- Psychosocial Determinants of Physical Activity Vary by Depression Severity
- Imagery Rescripting Effective as Childhood Abuse-Related PTSD Treatment
- Machine Learning Model Predicts COVID-19 Severity With Laboratory Data
- Donanemab Induces Amyloid Clearance in Early Alzheimer Disease
- Hospital-Treated Infections Earlier in Life Associated With Risk for Alzheimer, Parkinson Disease
- Neurostimulation Methods Compared for Treating Older Adults With Depression
- Pregnancy Anxiety May Predict Shorter Gestational Length
- Major Depression Increased 60% Among Older Adults From 2010 to 2019
- Expansion of Telehealth, OUD Medication Access During Pandemic Raised Retention
- Long-Term Lithium Exposure May Damage Kidney Function
- Veterans With IBS Experience Psychological Comorbidities, High Health Care Use
- Depression, Anxiety Reduce Likelihood of Achieving Minimal Disease Activity in Psoriatic Arthritis
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
Symptom Duration After COVID-19 Onset Studied in Autoimmune Rheumatic Diseases
Rate of Severe Clostridioides difficile Infections During COVID-19 Pandemic Highlights Value of Routine Diagnostics
COVID-19 Is Still Causing Drug Shortages That Impact Cancer Care
Pandemic Tied to Worse Pregnancy-Related Complications, Maternal Death
Psychotherapy Linked to Reduced Risk for Liver Disease in Alcohol Use Disorder
